GLP-1 drugs have shifted from medical to mainstream, and the impact is rippling far beyond health. From luxury to lifestyle, ...

Linda Yaccarino, former CEO of X (formerly Twitter) and ex-NBCUniversal ad exec, has reappeared as the CEO of eMed Population ...

Linda Yaccarino, the former X CEO who left the social media company last month in the wake of yet another Elon Musk ...

Yaccarino, who has a house in Woodbury, graduated from Deer Park High in 1981 with her twin sister, Lori. Both were elected ...

Even though Novo Nordisk warned that copycat versions of its obesity and diabetes drugs would hurt sales in the U.S., second-quarter sales saw a 67% rise year on year. More news covers telehealth ...

The effects of President Trump’s trade war on households are expected to be a big focus in earnings calls held by major ...

There is an opportunity to combine technology, lifestyle, and data in a new powerful way through the digital channels that ...

Despite not coming from a healthcare background, Yaccarino brings over a decade of experience in digital revenue and brand ...

Linda Yaccarino, the former CEO of Elon Musk 's social media platform X, has been appointed as the new CEO of eMed Population ...

Yaccarino, an advertising industry veteran, exited Elon Musk's X after two turbulent years during which she tried to revive ...

Linda Yaccarino, less than a month after stepping down as CEO of Elon Musk’s X, has found her next gig. Yaccarino has been ...